Notable Labs
Public companyPersonalized drug discovery for blood cancer.
What it does
Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships. https://www.notablelabs.com/careers
Next to it in Healthcare and bio · personalized drug discovery oncology
- Kyo DiagnosticsPlug and Play
Personalized healthcare business based on sensitivity testing on anticancer drugs for colorectal cancer.
- 株式会社キュライオPlug and Play
Curreio is a biotechnology platform that provides contract business for structural analysis using cryo-electron microscopy.
- 株式会社EpigeneronPlug and Play
Epigeneron Inc. is a Drug discovery and detection of gene mutation Company.
- インタープロテイン株式会社Plug and Play
Interprotein provides highly active modulators for protein-protein interaction (PPI) targets.
- Metagen TherapeuticsPlug and Play
Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
- モジュラス株式会社Plug and Play
Modulus Discovery is a preclinical-stage technology-driven drug discovery firm.
- OmniSciencePlug and Play
OmniScience is a leading AI organization advancing life science missions through unparalleled expertise in biology and data science.
- SyntheXSOSV SOSV IndieBio 03
Drugging the undruggable